Navigation Links
Antibody Drugs Market - New Industry Research Report Is Now Available for Pre-Order at Transparency Market Research
Date:8/26/2013

Albany, New York (PRWEB) August 26, 2013

Antibody drugs make use of the body’s own immune system to locate and eliminate cells which are responsible for the target disease. Antibody drugs have been successful in attracting the attention of researchers worldwide owing to their characteristic features such as fewer side effects and high efficacy in curing certain diseases which were previously untreatable.

Large scale research development is being conducted in the field of antibody drugs for the past two decades. By 2009, approximately 30 new antibody drugs were launched in the market. With an intention of launching new blockbuster drugs and to reform the pharmaceuticals industry, large pharmaceutical companies have begun to undertake aggressive steps to enter this market. Hence, it is expected that the antibody drugs segment will experience impressive growth in the global pharmaceuticals market.

Browse Report : http://www.transparencymarketresearch.com/antibody-drugs.html

Antibody drugs show promising efficacy for the treatment of certain diseases for which no equally effective treatment is available. Antibody drugs are primarily used for the treatment of diseases such as central nervous system ailments, allergic diseases, cancer, and infections. Globally, North America is viewed as the largest market for antibody drugs followed by Europe. However, infrastructural development in the healthcare system and growth in awareness regarding the treatment of chronic diseases may influence a rapid growth of this market in Asia and in other parts of the world.

Some of the market players in the antibody drugs industry are Abbott Laboratories, AstraZeneca, Bayer Ag, Genmab, Eli Lilly, Novartis, Merck KGaA, Daiichi Sankyo, Biogen Idec, some and others.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
North America
Asia Pacific
Europe
Rest of the World
This report provides comprehensive analysis of
Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
It provides distinctive graphics and exemplified SWOT analysis of major market segments

Browse all Market Research reports: http://www.transparencymarketresearch.com .

Read the full story at http://www.prweb.com/releases/2013/8/prweb11047517.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
2. Scientists Pinpoint Antibody That May Be Specific to MS Patients
3. NIH scientists map first steps in flu antibody development
4. Elevated Antibody Levels May Predict Rheumatoid Arthritis Risk
5. New monoclonal antibody inhibits tumor growth in advanced solid tumors in phase I clinical trial
6. Antibody-coated stents: Indication of disadvantages
7. Evolution in the antibody factory
8. Scientists ID Antibody That Might Boost Cancer Therapy
9. Your Autoantibody Profile Might Someday Help Spot Illness
10. Monoclonal antibody appears effective and safe in asthma Phase IIa trial
11. Healthcare Antibody Market Partnering Deals And Agreements Analysis in New Research Report at ReportsnReports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... September 19, 2017 , ... Trusted debt-reduction firm CreditAssociates, LLC has announced two ... in excess of $835 million in resolved debt for its clients. , Credit card ... of the categories of debt settled by the company. With more than a decade ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... Canyon Ranch to its recently formed Corporate Roundtable, a group of ... system and a sustainable world. , Canyon Ranch is a unique collection of ...
(Date:9/19/2017)... RESTON, VA (PRWEB) , ... ... ... future of medication management to the present, Mirixa Corporation recently unveiled the ... has continually redefined and reinvented how medication management services are delivered. Based ...
(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... Driving Dynamics ... Safety Training Company by Training Industry Inc. as part of its mission to continually ... , Selection to the first annual 2017 Top 20 Health and Safety Training Companies ...
(Date:9/19/2017)... ... September 19, 2017 , ... ... neurosurgeon, has received a big bump in sales after recently going live ... available on the Wal-Mart Stores-owned Jet.com, StackedNutrtion.com, RonnieColemanNutrition.com, RevNutrition.com and Go4ItNutrition.com. ...
Breaking Medicine News(10 mins):
(Date:8/29/2017)... 2017 ivWatch, LLC, the leading provider of continuous monitoring ... has been awarded an Innovative Technology contract from Vizient, Inc., the ... ... in the early detection of peripheral IV infiltration and extravasation events ... The Innovative Technology contract was awarded to ...
(Date:8/28/2017)... division of LightScalpel ®, LLC, is announcing its new line of ... American veterinary laser surgery innovation, Aesculight® is revolutionizing veterinary laser surgery once ... ... VetScalpel laser. Dr. Duclos practices veterinary dermatology at the Animal Skin and ... ...
(Date:8/24/2017)... -- BioBridges, a Career Portfolio® Management company providing integrated ... announce its corporate sponsorship of the upcoming fourth annual ... event will benefit charitable foundations affiliated with each band. ... to return once again as a sponsor of the ... Jason Falchuk , BioBridges Founding Partner. "Our life sciences ...
Breaking Medicine Technology: